image
Consumer Defensive - Packaged Foods - NASDAQ - US
$ 21.16
-5.54 %
$ 265 M
Market Cap
66.13
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one LFVN stock under the worst case scenario is HIDDEN Compared to the current market price of 21.2 USD, LifeVantage Corporation is HIDDEN

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one LFVN stock under the base case scenario is HIDDEN Compared to the current market price of 21.2 USD, LifeVantage Corporation is HIDDEN

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one LFVN stock under the best case scenario is HIDDEN Compared to the current market price of 21.2 USD, LifeVantage Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
200 M REVENUE
-6.20%
4.33 M OPERATING INCOME
1.71%
2.94 M NET INCOME
15.63%
12.2 M OPERATING CASH FLOW
78.63%
-2.24 M INVESTING CASH FLOW
26.61%
-14.4 M FINANCING CASH FLOW
-511.67%
47.2 M REVENUE
-3.51%
2.57 M OPERATING INCOME
-11.68%
1.83 M NET INCOME
39.92%
-583 K OPERATING CASH FLOW
-22.58%
-345 K INVESTING CASH FLOW
-24.10%
-1.83 M FINANCING CASH FLOW
33.31%
Balance Sheet LifeVantage Corporation
image
Current Assets 37.6 M
Cash & Short-Term Investments 16.9 M
Receivables 3.26 M
Other Current Assets 17.5 M
Non-Current Assets 22.7 M
Long-Term Investments 0
PP&E 17.4 M
Other Non-Current Assets 5.27 M
Current Liabilities 22.3 M
Accounts Payable 5.85 M
Short-Term Debt 3.62 M
Other Current Liabilities 12.8 M
Non-Current Liabilities 12 M
Long-Term Debt 11.8 M
Other Non-Current Liabilities 198 K
EFFICIENCY
Earnings Waterfall LifeVantage Corporation
image
Revenue 200 M
Cost Of Revenue 41.4 M
Gross Profit 159 M
Operating Expenses 154 M
Operating Income 4.33 M
Other Expenses 1.4 M
Net Income 2.94 M
RATIOS
79.30% GROSS MARGIN
79.30%
2.16% OPERATING MARGIN
2.16%
1.47% NET MARGIN
1.47%
11.30% ROE
11.30%
4.87% ROA
4.87%
7.03% ROIC
7.03%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis LifeVantage Corporation
image
Net Income 2.94 M
Depreciation & Amortization 3.58 M
Capital Expenditures -2.24 M
Stock-Based Compensation 3.28 M
Change in Working Capital 2.38 M
Others 2.14 M
Free Cash Flow 9.95 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets LifeVantage Corporation
image
Wall Street analysts predict an average 1-year price target for LFVN of $30.3 , with forecasts ranging from a low of $26 to a high of $35 .
LFVN Lowest Price Target Wall Street Target
26 USD 22.87%
LFVN Average Price Target Wall Street Target
30.3 USD 43.35%
LFVN Highest Price Target Wall Street Target
35 USD 65.41%
4. DIVIDEND ANALYSIS
0.34% DIVIDEND YIELD
0.04 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership LifeVantage Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
3.63 K USD 1
0-3 MONTHS
10.8 K USD 2
3-6 MONTHS
3.61 K USD 1
6-9 MONTHS
4.27 K USD 2
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Dec 16, 2024
Bought 3.63 K USD
Lewis Darwin
Director
+ 227
15.9995 USD
4 months ago
Sep 17, 2024
Bought 61.4 USD
Lewis Darwin
Director
+ 6
10.2342 USD
4 months ago
Sep 17, 2024
Bought 3.56 K USD
Lewis Darwin
Director
+ 345
10.3101 USD
4 months ago
Sep 03, 2024
Bought 4.44 K USD
Mauro Garry Paul
Director
+ 600
7.405 USD
4 months ago
Sep 03, 2024
Bought 2.31 K USD
Mauro Garry Paul
Director
+ 312
7.405 USD
4 months ago
Sep 03, 2024
Bought 474 USD
Mauro Garry Paul
Director
+ 64
7.405 USD
7 months ago
Jun 14, 2024
Bought 103 USD
Lewis Darwin
Director
+ 14
7.3592 USD
7 months ago
Jun 14, 2024
Bought 3.51 K USD
Lewis Darwin
Director
+ 475
7.3828 USD
10 months ago
Mar 15, 2024
Bought 62.4 USD
Lewis Darwin
Director
+ 9
6.9356 USD
10 months ago
Mar 15, 2024
Bought 3.08 K USD
Lewis Darwin
Director
+ 440
6.9999 USD
11 months ago
Feb 02, 2024
Bought 917 USD
Mauro Garry Paul
Director
+ 162
5.66 USD
11 months ago
Feb 02, 2024
Bought 211 USD
Mauro Garry Paul
Director
+ 37
5.71 USD
1 year ago
Dec 15, 2023
Bought 34.4 USD
Lewis Darwin
Director
+ 5
6.8767 USD
1 year ago
Dec 15, 2023
Bought 3.08 K USD
Lewis Darwin
Director
+ 455
6.7762 USD
1 year ago
Nov 20, 2023
Sell 33 K USD
BEINDORFF MICHAEL A
Director
- 5500
6 USD
1 year ago
Nov 16, 2023
Bought 23.6 K USD
Mauro Garry Paul
Director
+ 4970
4.7473 USD
1 year ago
Nov 15, 2023
Bought 9.41 K USD
Mauro Garry Paul
Director
+ 2024
4.6498 USD
1 year ago
Nov 16, 2023
Bought 10.7 K USD
Mauro Garry Paul
Director
+ 2262
4.7473 USD
1 year ago
Nov 16, 2023
Bought 2.47 K USD
Mauro Garry Paul
Director
+ 520
4.7473 USD
1 year ago
Sep 22, 2023
Bought 28.6 K USD
Lewis Darwin
Director
+ 4124
6.9427 USD
1 year ago
Sep 05, 2023
Bought 3.24 K USD
Mauro Garry Paul
Director
+ 425
7.632 USD
1 year ago
Sep 05, 2023
Bought 840 USD
Mauro Garry Paul
Director
+ 110
7.632 USD
1 year ago
Sep 05, 2023
Bought 191 USD
Mauro Garry Paul
Director
+ 25
7.632 USD
1 year ago
Aug 25, 2023
Bought 27.2 K USD
Dayton Judd
+ 5490
4.952 USD
1 year ago
Aug 24, 2023
Bought 34.8 K USD
Dayton Judd
+ 7226
4.821 USD
1 year ago
Aug 23, 2023
Bought 18 K USD
Dayton Judd
+ 3788
4.7647 USD
1 year ago
Aug 11, 2023
Bought 101 K USD
Radoff Bradley Louis
+ 20000
5.0666 USD
1 year ago
May 25, 2023
Bought 8.42 K USD
BEINDORFF MICHAEL A
Director
+ 2000
4.21 USD
1 year ago
May 24, 2023
Bought 13.2 K USD
BEINDORFF MICHAEL A
Director
+ 3000
4.4 USD
1 year ago
May 12, 2023
Bought 631 USD
Mauro Garry Paul
Director
+ 150
4.2074 USD
1 year ago
May 10, 2023
Bought 14.9 K USD
Mauro Garry Paul
Director
+ 3650
4.0799 USD
1 year ago
May 10, 2023
Bought 694 USD
Mauro Garry Paul
Director
+ 170
4.0799 USD
1 year ago
May 09, 2023
Bought 3.88 K USD
Lewis Darwin
Director
+ 1000
3.8784 USD
2 years ago
Feb 07, 2022
Bought 34.9 K USD
BEINDORFF MICHAEL A
Director
+ 7193
4.85 USD
3 years ago
Dec 07, 2021
Sell 13.3 K USD
BEINDORFF MICHAEL A
Director
- 2000
6.63 USD
3 years ago
Dec 08, 2021
Sell 34 K USD
BEINDORFF MICHAEL A
Director
- 5143
6.62 USD
4 years ago
Sep 16, 2020
Sell 17 K USD
Rose Justin
Chief Sales &Marketing Officer
- 1250
13.58 USD
4 years ago
Aug 19, 2020
Sell 16.6 K USD
Rose Justin
Chief Sales Officer
- 1250
13.26 USD
4 years ago
Aug 19, 2020
Sell 59.1 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
13.13 USD
4 years ago
Jul 15, 2020
Sell 16.9 K USD
Rose Justin
Chief Sales Officer
- 1250
13.55 USD
4 years ago
Jul 15, 2020
Sell 60.8 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
13.5 USD
4 years ago
Jun 17, 2020
Sell 64.8 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
14.41 USD
4 years ago
Jun 17, 2020
Sell 18.2 K USD
Rose Justin
Chief Sales Officer
- 1250
14.6 USD
4 years ago
May 20, 2020
Sell 17.5 K USD
Rose Justin
Chief Sales Officer
- 1250
14 USD
4 years ago
May 20, 2020
Sell 63 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
14.01 USD
4 years ago
Apr 15, 2020
Sell 30 K USD
Rose Justin
Chief Sales Officer
- 2500
12 USD
4 years ago
Apr 15, 2020
Sell 51.1 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
11.36 USD
4 years ago
Mar 18, 2020
Sell 37.4 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
8.3 USD
4 years ago
Feb 19, 2020
Sell 19.6 K USD
Rose Justin
Chief Sales Officer
- 1250
15.64 USD
4 years ago
Feb 19, 2020
Sell 69.8 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
15.52 USD
5 years ago
Jan 15, 2020
Sell 69.7 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
15.48 USD
5 years ago
Dec 18, 2019
Sell 70.6 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
15.68 USD
5 years ago
Nov 20, 2019
Sell 63.6 K USD
Jensen Darren Jay
Chief Executive Officer
- 4500
14.13 USD
6 years ago
Nov 30, 2018
Bought 19.8 K USD
Greer Raymond B
Director
+ 1500
13.22 USD
6 years ago
Nov 26, 2018
Bought 13.7 K USD
Mauro Garry Paul
Director
+ 1150
11.94 USD
7 years ago
Nov 13, 2017
Bought 10.1 K USD
Jensen Darren Jay
Chief Executive Officer
+ 2000
5.0649 USD
7 years ago
Sep 15, 2017
Bought 15 K USD
Lewis Darwin
Director
+ 3500
4.29 USD
7 years ago
Sep 15, 2017
Bought 14.7 K USD
Mauro Garry Paul
Director
+ 3500
4.2 USD
7 years ago
Sep 12, 2017
Bought 420 USD
Jensen Darren Jay
Chief Executive Officer
+ 100
4.2 USD
7 years ago
Sep 12, 2017
Bought 9.71 K USD
Jensen Darren Jay
Chief Executive Officer
+ 2300
4.22 USD
7 years ago
May 18, 2017
Bought 8.68 K USD
Jensen Darren Jay
Chief Executive Officer
+ 2000
4.34 USD
7 years ago
Feb 14, 2017
Bought 2.32 K USD
BEINDORFF MICHAEL A
Director
+ 358
6.47 USD
7 years ago
Feb 14, 2017
Bought 522 USD
BEINDORFF MICHAEL A
Director
+ 80
6.53 USD
7 years ago
Feb 13, 2017
Bought 11.4 K USD
Mauro Garry Paul
Director
+ 1700
6.71 USD
7 years ago
Feb 13, 2017
Bought 1.52 K USD
Mauro Garry Paul
Director
+ 225
6.75 USD
7 years ago
Feb 13, 2017
Bought 1.15 K USD
Mauro Garry Paul
Director
+ 170
6.75 USD
7 years ago
Feb 13, 2017
Bought 1.15 K USD
Mauro Garry Paul
Director
+ 170
6.75 USD
7 years ago
Feb 13, 2017
Bought 13.4 K USD
TOOLE DAVID J
Director
+ 2000
6.68 USD
7 years ago
Feb 13, 2017
Bought 6.63 K USD
Metzger George
Director
+ 1000
6.63 USD
7 years ago
Feb 13, 2017
Bought 10.1 K USD
Rose Justin
Chief Sales Officer
+ 1500
6.75 USD
7 years ago
Feb 13, 2017
Bought 15.6 K USD
BEINDORFF MICHAEL A
Director
+ 2300
6.79 USD
7 years ago
Feb 13, 2017
Bought 10.1 K USD
Jensen Darren Jay
Chief Executive Officer
+ 1500
6.75 USD
9 years ago
Dec 11, 2015
Bought 7.99 K USD
Jaggi Mark R.
Chief Financial Officer
+ 1000
7.99 USD
9 years ago
Dec 10, 2015
Bought 20.2 K USD
Metzger George
Director
+ 2500
8.06 USD
9 years ago
Nov 30, 2015
Bought 5.09 K USD
Jensen Darren Jay
Chief Executive Officer
+ 600
8.48 USD
9 years ago
Nov 11, 2015
Bought 754 USD
BEINDORFF MICHAEL A
Director
+ 89
8.47 USD
9 years ago
Nov 11, 2015
Bought 754 USD
BEINDORFF MICHAEL A
Director
+ 89
8.47 USD
9 years ago
Sep 14, 2015
Bought 3.75 K USD
Urban Robert M.
Chief Operating Officer
+ 5000
0.7495 USD
9 years ago
Apr 06, 2015
Sell 15.7 K USD
Cutler Rob
General Counsel
- 20252
0.776 USD
9 years ago
Mar 10, 2015
Bought 3.9 K USD
BEINDORFF MICHAEL A
Director
+ 5000
0.78 USD
9 years ago
Feb 17, 2015
Bought 2.65 K USD
Talbott Shawn M.
Chief Science Officer
+ 2600
1.0199 USD
10 years ago
Sep 15, 2014
Bought 10 K USD
Talbott Shawn M.
Chief Science Officer
+ 8000
1.2499 USD
11 years ago
Dec 02, 2013
Bought 19.4 K USD
BEINDORFF MICHAEL A
Director
+ 10000
1.94 USD
11 years ago
Dec 02, 2013
Bought 776 USD
BEINDORFF MICHAEL A
Director
+ 400
1.94 USD
11 years ago
Nov 22, 2013
Bought 90.5 K USD
OKUMOTO RICHARD Y
Director
+ 50000
1.81 USD
11 years ago
May 14, 2013
Bought 122 K USD
OKUMOTO RICHARD Y
Director
+ 50000
2.44 USD
11 years ago
Apr 01, 2013
Sell 16.6 K USD
Cutler Rob
General Counsel
- 7000
2.3775 USD
12 years ago
Sep 14, 2012
Bought 9.9 K USD
Thompson Ryan
Senior VP of Sales
+ 2920
3.39 USD
12 years ago
Sep 14, 2012
Bought 33.7 K USD
BEINDORFF MICHAEL A
Director
+ 10000
3.37 USD
12 years ago
Sep 14, 2012
Bought 50.2 K USD
BEINDORFF MICHAEL A
Director
+ 15000
3.35 USD
12 years ago
Sep 14, 2012
Bought 5.04 K USD
BEINDORFF MICHAEL A
Director
+ 1500
3.36 USD
12 years ago
Sep 14, 2012
Bought 4.95 K USD
BEINDORFF MICHAEL A
Director
+ 1500
3.3 USD
12 years ago
Sep 14, 2012
Bought 539 USD
BEINDORFF MICHAEL A
Director
+ 160
3.37 USD
12 years ago
Sep 14, 2012
Bought 1.81 K USD
BEINDORFF MICHAEL A
Director
+ 540
3.35 USD
12 years ago
Mar 15, 2012
Bought 14.4 K USD
BEINDORFF MICHAEL A
Director
+ 5000
2.89 USD
12 years ago
Mar 15, 2012
Bought 13.3 K USD
BEINDORFF MICHAEL A
Director
+ 5000
2.66 USD
12 years ago
Mar 14, 2012
Bought 17.8 K USD
BEINDORFF MICHAEL A
Director
+ 5000
3.56 USD
12 years ago
Mar 14, 2012
Bought 25.3 K USD
BEINDORFF MICHAEL A
Director
+ 8900
2.84 USD
12 years ago
Mar 14, 2012
Bought 6.85 K USD
BEINDORFF MICHAEL A
Director
+ 2500
2.74 USD
12 years ago
Mar 14, 2012
Bought 16.9 K USD
BEINDORFF MICHAEL A
Director
+ 5000
3.38 USD
12 years ago
Mar 14, 2012
Bought 1.36 K USD
BEINDORFF MICHAEL A
Director
+ 500
2.73 USD
12 years ago
Mar 14, 2012
Bought 17.4 K USD
BEINDORFF MICHAEL A
Director
+ 5000
3.48 USD
12 years ago
Mar 14, 2012
Bought 22.9 K USD
BEINDORFF MICHAEL A
Director
+ 8100
2.83 USD
12 years ago
Mar 14, 2012
Bought 16.4 K USD
BEINDORFF MICHAEL A
Director
+ 5000
3.28 USD
12 years ago
Mar 09, 2012
Bought 9.32 K USD
BEINDORFF MICHAEL A
Director
+ 3400
2.74 USD
12 years ago
Mar 06, 2012
Bought 11.4 K USD
BEINDORFF MICHAEL A
Director
+ 5000
2.28 USD
12 years ago
Mar 06, 2012
Bought 17 K USD
BEINDORFF MICHAEL A
Director
+ 7500
2.27 USD
12 years ago
Mar 05, 2012
Bought 11.2 K USD
BEINDORFF MICHAEL A
Director
+ 5000
2.25 USD
12 years ago
Mar 02, 2012
Bought 2.39 K USD
BEINDORFF MICHAEL A
Director
+ 1100
2.17 USD
12 years ago
Feb 23, 2012
Bought 9.15 K USD
BEINDORFF MICHAEL A
Director
+ 5000
1.83 USD
12 years ago
Feb 23, 2012
Bought 9.1 K USD
BEINDORFF MICHAEL A
Director
+ 5000
1.82 USD
12 years ago
Feb 22, 2012
Bought 7.77 K USD
BEINDORFF MICHAEL A
Director
+ 4200
1.85 USD
12 years ago
Feb 21, 2012
Bought 10.3 K USD
BEINDORFF MICHAEL A
Director
+ 5800
1.77 USD
13 years ago
Dec 14, 2011
Bought 5.2 K USD
Mauro Garry Paul
Director
+ 3796
1.37 USD
13 years ago
Dec 14, 2011
Bought 512 USD
Mauro Garry Paul
Director
+ 374
1.37 USD
13 years ago
Dec 14, 2011
Bought 509 USD
Mauro Garry Paul
Director
+ 374
1.36 USD
13 years ago
Dec 14, 2011
Bought 242 USD
Mauro Garry Paul
Director
+ 177
1.37 USD
13 years ago
Dec 14, 2011
Bought 233 USD
Mauro Garry Paul
Director
+ 170
1.37 USD
13 years ago
Dec 13, 2011
Sell 143 K USD
Brown David Whitney
President, LifeVantage Network
- 100000
1.43 USD
13 years ago
Dec 13, 2011
Sell 172 K USD
Robinson Douglas C.
President & CEO
- 120000
1.43 USD
13 years ago
Dec 13, 2011
Sell 115 K USD
CRAPO JAMES D
Director
- 80185
1.43 USD
13 years ago
Dec 06, 2011
Sell 12.4 K USD
CRAPO JAMES D
Director
- 8700
1.4306 USD
13 years ago
Dec 07, 2011
Sell 18.3 K USD
CRAPO JAMES D
Director
- 12556
1.4535 USD
13 years ago
Dec 02, 2011
Sell 23.9 K USD
CRAPO JAMES D
Director
- 16500
1.4458 USD
13 years ago
Dec 05, 2011
Sell 81.8 K USD
CRAPO JAMES D
Director
- 56934
1.4367 USD
15 years ago
Dec 11, 2009
Bought 25 K USD
CRAPO JAMES D
Director
+ 124875
0.2 USD
15 years ago
Dec 11, 2009
Bought 31.2 K USD
CRAPO JAMES D
Director
+ 62500
0.5 USD
15 years ago
Dec 11, 2009
Bought 74.9 K USD
McCord Joe M
Director
+ 374625
0.2 USD
15 years ago
Dec 11, 2009
Bought 93.8 K USD
McCord Joe M
Director
+ 187500
0.5 USD
15 years ago
Apr 07, 2009
Bought 50 K USD
Brown David Whitney
Chief Executive Officer
+ 100000
0.5 USD
15 years ago
Apr 07, 2009
Bought 20 K USD
Brown David Whitney
Chief Executive Officer
+ 100000
0.2 USD
15 years ago
Mar 11, 2009
Bought 75 K USD
Mauro Garry Paul
Director
+ 150000
0.5 USD
15 years ago
Mar 11, 2009
Bought 30 K USD
Mauro Garry Paul
Director
+ 150000
0.2 USD
15 years ago
Apr 07, 2009
Bought 25 K USD
Amman Bradford K.
CFO, Treasurer, Secretary
+ 50000
0.5 USD
15 years ago
Apr 07, 2009
Bought 10 K USD
Amman Bradford K.
CFO, Treasurer, Secretary
+ 50000
0.2 USD
15 years ago
Apr 07, 2009
Bought 50 K USD
Jones Richard Doutre
Director
+ 100000
0.5 USD
15 years ago
Apr 07, 2009
Bought 20 K USD
Jones Richard Doutre
Director
+ 100000
0.2 USD
15 years ago
Apr 07, 2009
Bought 10 K USD
CRAPO JAMES D
Director
+ 50000
0.2 USD
15 years ago
Apr 07, 2009
Bought 25 K USD
CRAPO JAMES D
Director
+ 50000
0.5 USD
15 years ago
Mar 11, 2009
Bought 100 K USD
Thompson Jack R.
Director
+ 500000
0.2 USD
15 years ago
Mar 11, 2009
Bought 250 K USD
Thompson Jack R.
Director
+ 500000
0.5 USD
16 years ago
Dec 05, 2008
Bought 1.9 K USD
Thompson Jack R.
Director
+ 20000
0.095 USD
16 years ago
Nov 19, 2008
Bought 2.1 K USD
Thompson Jack R.
Director
+ 20000
0.105 USD
16 years ago
Nov 18, 2008
Bought 2 K USD
Thompson Jack R.
Director
+ 20000
0.1 USD
18 years ago
Mar 23, 2006
Bought 140 K USD
HEUVELEN JOHN VAN
Director
+ 80000
1.745 USD
19 years ago
Apr 18, 2005
Bought 30.5 K USD
HEUVELEN JOHN VAN
Director
+ 15264
2 USD
19 years ago
May 15, 2005
Bought 62.5 K USD
Krejci James
Director
+ 25000
2.5 USD
19 years ago
May 15, 2005
Bought 50 K USD
Krejci James
Director
+ 25000
2 USD
19 years ago
May 16, 2005
Bought 25 K USD
SEVERANCE H LEIGH
Director
+ 12500
2 USD
19 years ago
May 16, 2005
Bought 31.2 K USD
SEVERANCE H LEIGH
Director
+ 12500
2.5 USD
19 years ago
May 16, 2005
Bought 31.2 K USD
SEVERANCE H LEIGH
Director
+ 12500
2.5 USD
19 years ago
May 16, 2005
Bought 25 K USD
SEVERANCE H LEIGH
Director
+ 12500
2 USD
19 years ago
Feb 08, 2005
Bought 100 K USD
SEVERANCE H LEIGH
Director
+ 200858
0.5 USD
20 years ago
Feb 04, 2005
Bought 254 K USD
SEVERANCE H LEIGH
Director
+ 126884
2 USD
20 years ago
Feb 04, 2005
Bought 254 K USD
SEVERANCE H LEIGH
Director
+ 126884
2 USD
20 years ago
Feb 04, 2005
Bought 86.3 K USD
SEVERANCE H LEIGH
Director
+ 43141
2 USD
20 years ago
Feb 04, 2005
Bought 86.3 K USD
SEVERANCE H LEIGH
Director
+ 43141
2 USD
20 years ago
Feb 04, 2005
Bought 15.2 K USD
SEVERANCE H LEIGH
Director
+ 7614
2 USD
20 years ago
Feb 04, 2005
Bought 15.2 K USD
SEVERANCE H LEIGH
Director
+ 7614
2 USD
20 years ago
Feb 03, 2005
Bought 10.2 K USD
SEVERANCE H LEIGH
Director
+ 5077
2 USD
20 years ago
Feb 03, 2005
Bought 10.2 K USD
SEVERANCE H LEIGH
Director
+ 5077
2 USD
20 years ago
Jan 17, 2005
Bought 76.5 K USD
SEVERANCE H LEIGH
Director
+ 38250
2 USD
20 years ago
Jan 17, 2005
Bought 76.5 K USD
SEVERANCE H LEIGH
Director
+ 38250
2 USD
19 years ago
Jul 06, 2005
Bought 748 K USD
CRAPO JAMES D
Director
+ 550000
1.36 USD
19 years ago
Jul 06, 2005
Sell 748 K USD
Myhill Paul Robert
VP, Treasurer, Secretary, CFO
- 550000
1.36 USD
19 years ago
May 16, 2005
Bought 50 K USD
CRAPO JAMES D
Director
+ 25000
2 USD
19 years ago
May 16, 2005
Bought 0 USD
CRAPO JAMES D
Director
+ 0
2.5 USD
19 years ago
May 16, 2005
Bought 0 USD
Baz Javier
Director
+ 0
2.5 USD
19 years ago
May 16, 2005
Bought 686 K USD
Baz Javier
Director
+ 342814
2 USD
19 years ago
Apr 04, 2005
Bought 20.1 K USD
Streets Daniel W
Treasurer, Secretary, CFO
+ 40170
0.5 USD
19 years ago
Apr 04, 2005
Sell 143 K USD
Driscoll William Joseph
President, CEO
- 285904
0.5 USD
7. News
LifeVantage Welcomes Todd Thompson as Chief Information and Innovation Officer Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage's growth and digital transformation Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage's growth and digital transformation globenewswire.com - 2 weeks ago
LifeVantage Launches 2025 Vision with “Drive ERA” Theme and International Expansion Plans for Evolve Compensation Plan and the MindBody GLP-1 System™ New Innovations and Incentives Empower Consultants to Accelerate Business Growth in 2025 New Innovations and Incentives Empower Consultants to Accelerate Business Growth in 2025 globenewswire.com - 2 weeks ago
Undercovered Dozen: Fannie Mae, Civitas Resources, LifeVantage, ZenaTech + The 'Undercovered' Dozen series highlights lesser-covered stocks, offering investment ideas and encouraging discussion among investors. Pacifica Yield highlights Brookfield Infrastructure's subordinated notes with a 32% discount opportunity and a 7.2% yield, backed by a strong balance sheet and diversified assets. Cerence Inc.'s partnership with Nvidia boosts its AI capabilities according to Uttam Dey, but caution is advised due to recent stock surge and potential volatility. seekingalpha.com - 2 weeks ago
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs from the likes of Zepbound and Ozempic. The recent launch has exceeded expectations by a wide margin. On Wednesday, the company preannounced stellar Q2/FY2025 results. Preliminary Q2/FY2025 revenues of $67.5 million exceeded consensus expectations by more than 30% and active accounts of approximately 146,000 represented the highest level in almost two years. seekingalpha.com - 3 weeks ago
LifeVantage to Participate in the 27th Annual ICR Conference SALT LAKE CITY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the 27th Annual ICR Conference to be held January 13-15, 2025 in Orlando, FL. globenewswire.com - 3 weeks ago
Top 3 Risk Off Stocks That May Collapse This Month As of Dec. 20, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. benzinga.com - 1 month ago
LifeVantage Corporation (LFVN) Q1 2025 Earnings Call Transcript LifeVantage Corporation (NASDAQ:LFVN ) Q1 2025 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President & Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Douglas Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by. seekingalpha.com - 3 months ago
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2025 SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024. globenewswire.com - 3 months ago
LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid December 16, 2024 to all stockholders of record at the close of business on December 2, 2024. globenewswire.com - 3 months ago
LifeVantage to Announce First Quarter Fiscal Year 2025 Results on October 29, 2024 SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2024, after the stock market closes on Tuesday, October 29, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. globenewswire.com - 3 months ago
LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger Hormones and Reduce Cravings, Supporting Sustainable Weight and Visceral Fat Loss While Maintaining Muscle ‡Ω globenewswire.com - 3 months ago
LifeVantage Announces Update to Evolve Compensation Plan with New Sharing Bonus Enhancements simplify the path to success for independent Consultants Enhancements simplify the path to success for independent Consultants globenewswire.com - 4 months ago
8. Profile Summary

LifeVantage Corporation LFVN

image
COUNTRY US
INDUSTRY Packaged Foods
MARKET CAP $ 265 M
Dividend Yield 0.34%
Description LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.
Contact 3300 North Triumph Boulevard, Lehi, UT, 84043 https://www.lifevantage.com
IPO Date April 7, 1994
Employees 222
Officers Mr. Carl A. Aure CPA Chief Financial Officer Ms. Julie Boyster Chief Marketing Officer Mr. Steven R. Fife CPA President, Chief Executive Officer & Director